Skip to main content
Submit application details
Industry Insights

Industry Insights · Brain–Computer Interface

What decides BCI: electrodes, encapsulation and systems engineering

When funding lands on electrodes, encapsulation and manufacturable use-cases, BCI's competition has moved from algorithms to hardware and materials.

Published：2026-05-20Updated：2026-05-20

Updated
Illustration of BCI electrode–chip–encapsulation–stimulation systems engineering
The systems-engineering stack of an implantable BCI: electrode at the front, then chip/wireless, encapsulation and system reliability, forming a closed-loop stimulation. Illustrative.
In short: In May 2026 domestic BCI funding clustered with striking consistency around electrode–chip–encapsulation–stimulation systems engineering, not algorithms alone. For implantable BCI the core barrier is first the electrode (long-term signal stability, controlled impedance, acceptable tissue reaction, flexible materials to limit inflammation/scarring, encapsulation resisting fluids and corrosion), then chip and wireless (power, heat, battery, miniaturization), then encapsulation and system reliability under body fluids, motion and years of implantation.

Algorithms are just the last layer

Outside discussion fixates on algorithms — recognizing intent, translating commands. But from an industrial view, algorithms are the last layer; what decides clinical and commercial viability is front-end hardware and systems engineering.

The electrode is the first barrier

Electrodes must solve more than 'how many channels' — whether signals stay stable after long implantation, impedance stays controlled, tissue reaction stays acceptable, flexible materials limit inflammation and scarring, and encapsulation resists fluids and corrosion for years. Many projects work early but degrade — a top failure mode.

Chip, wireless and encapsulation reliability

High-throughput implants mean massive signals acquired, amplified, filtered, compressed and transmitted in real time — high power causes heat, unstable transmission breaks the loop, insufficient miniaturization burdens implantation. Encapsulation and the system must stay stable in fluids, motion and years of implantation, unlike ordinary consumer electronics.

The BIO angle

Electrode insulation, lead/device encapsulation, and a flexible interface that limits foreign-body response all land on medical silicone and polymers. BIO supplies implant-grade (unrestricted) silicone selection, adhesion/primer solutions to Pt/Ir and polyimide substrates, and regulatory documentation — exactly BCI's most critical encapsulation and interface layer.

FAQ

What is BCI's biggest engineering barrier?

For implantable BCI it's electrode long-term stability and flexible materials/encapsulation first, then chip/wireless and in-body system reliability; algorithms come relatively later.

What role does silicone play in BCI?

Neural-electrode insulation, device encapsulation and the tissue interface — its low modulus and biocompatibility limit foreign-body response; long-term implants need unrestricted, platinum-cure grades.

Can silicone fully waterproof active electronics?

Not entirely — silicone is permeable to moisture/oxygen, so long-term active implants need hermetic packaging, with silicone as the outer flexible insulation and tissue interface.

Related reading

Browse all insights →

Note: an original analysis compiled from public industry information; figures and conclusions per official/original sources. Not investment advice.

Building in China's medical-device market?

From advanced medical silicone/polymers to material selection, regulatory and supply, BIO helps global and local partners move from selection to landed supply in China.

Contact BIO Silicone sourcing guide